Hepatitis B surface antigen (HBsAg) prevalence (%) in Cameroon
Cameroon: Hepatitis B surface antigen (HBsAg) prevalence was 1.8% in 2024. ▼ Falling
Hepatitis B surface antigen (HBsAg) prevalence in Cameroon, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Cameroon is 1.8%, measured in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 5.3% on the previous year and down 5.3% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Cameroon peaked at 2.1% in 2018 and was at its lowest, 1.8%, in 2024.
Cameroon ranks 13th of 194 countries on this measure, in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Cameroon, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.9% | — |
| 2016 | 2.0% | +5.3% |
| 2017 | 2.0% | +0.0% |
| 2018 | 2.1% | +5.0% |
| 2019 | 2.1% | +0.0% |
| 2020 | 2.1% | +0.0% |
| 2021 | 2.0% | -4.8% |
| 2022 | 2.0% | +0.0% |
| 2023 | 1.9% | -5.0% |
| 2024 | 1.8% | -5.3% |
Cameroon compared with similar countries
- Cameroon's 1.8% is above the median for lower middle income countries, which is 0.6%, 3.0× the median. (47 countries reporting)
- Cameroon's 1.8% is above the median for Sub-Saharan Africa, which is 1.1%, 1.7× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.0% | 1.9% | 2.1% | 5 |
| 2020s | 2.0% | 1.8% | 2.1% | 5 |
Countries ranked near Cameroon
More health data for Cameroon
- Un projection of annual infant deaths, annual growth rate -1.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7821 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 786.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12,841 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 17 (2025)
- Population ages 00-04, female, annual growth rate 1.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0746 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.21 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Cameroon?
- Hepatitis b surface antigen (hbsag) prevalence in Cameroon was 1.8% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Cameroon?
- The highest recorded value was 2.1% in 2018.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Cameroon?
- The lowest recorded value was 1.8% in 2024.
- How does Cameroon rank for hepatitis b surface antigen (hbsag) prevalence?
- Cameroon ranks 13th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Cameroon?
- Over the last ten years it is down 5.3%. The long-run trend across the full record is falling.
- Where does this Cameroon data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).